Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | GSK3B | P49841 | 4/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30846519 | 0.81 | GSK3B (0.42) | MAOAALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL31151816 | 0.81 | MAOA (0.39) | MAOAALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL12264201 | 0.78 | MAOA (0.46) | MAOAALDH1A1SMN1; SMN2GSK3BRAB9A | |
| SCHEMBL28820816 | 0.77 | BCHE (0.39) | MAOAMAPTKDM1A | |
| SCHEMBL28820660 | 0.77 | BCHE (0.39) | MAOAMAPTKDM1A | |
| SCHEMBL28863165 | 0.77 | ALDH1A1 (0.35) | MAOAALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL1412732 | 0.75 | MAOA (0.43) | MAOAALDH1A1SMN1; SMN2GSK3BRAB9A | |
| SCHEMBL7138108 | 0.75 | MAOA (0.43) | MAOAALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL29814949 | 0.73 | ERBB2 (0.37) | MAOAALDH1A1HPGDGSK3BRAB9A | |
| SCHEMBL29815013 | 0.73 | APP (0.35) | MAPTSMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109020918-B | Synthesis method of 3-methyl-2-benzothiazolinone hydrazone hydrochloride and hydrate thereof | 青岛贞开生物医药技术有限公司 | 2022-04-19 | — | — | CN | claimed |
| CN-109020918-A | The synthetic method of 3- methyl-2-benzothiazolinone hydrazone hydrochloride and its hydrate | 南京艾普特生物医药有限公司 | 2018-12-18 | — | — | CN | claimed |
| CN-117706870-A | Photosensitive solder resist resin composition, photosensitive solder resist insulating film and electronic component | 杭州福斯特电子材料有限公司 | 2024-03-15 | — | — | CN | disclosed |
| CN-115074734-B | Copper-reducing additive for aluminum substrate circuit board and preparation method and use method thereof | 深圳市板明科技股份有限公司 | 2022-11-08 | — | — | CN | disclosed |
| CN-115074734-A | Copper-reducing additive for aluminum substrate circuit board and preparation method and use method thereof | 深圳市板明科技股份有限公司 | 2022-09-20 | — | — | CN | disclosed |
| CN-109020918-B | Synthesis method of 3-methyl-2-benzothiazolinone hydrazone hydrochloride and hydrate thereof | 青岛贞开生物医药技术有限公司 | 2022-04-19 | — | — | CN | disclosed |
| CN-109020918-A | The synthetic method of 3- methyl-2-benzothiazolinone hydrazone hydrochloride and its hydrate | 南京艾普特生物医药有限公司 | 2018-12-18 | — | — | CN | disclosed |
| CN-109020918-A | The synthetic method of 3- methyl-2-benzothiazolinone hydrazone hydrochloride and its hydrate | 南京艾普特生物医药有限公司 | 2018-12-18 | — | — | CN | disclosed |
| CN-102484326-B | Anisotropic conductive material, connection structure, and method for manufacturing connection structure | SEKISUI CHEMICAL CO LTD | 2014-12-10 | — | — | CN | disclosed |
| CN-102471253-B | Curable composition, connection structure, and mercapto group-containing (meth) acrylate compound | SEKISUI CHEMICAL CO LTD | 2013-11-13 | — | — | CN | disclosed |
| CN-102484326-A | Anisotropic conductive material, connection structure, and method for manufacturing connection structure | SEKISUI CHEMICAL CO LTD | 2012-05-30 | — | — | CN | disclosed |
| CN-102471253-A | Curable composition, connection structure, and mercapto group-containing (meth) acrylate compound | SEKISUI CHEMICAL CO LTD | 2012-05-23 | — | — | CN | disclosed |